PTPN14 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 7.08610004007681E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.62350000000511E-05 |
Normal-vs-Stage2 |
1.52244999999107E-05 |
Normal-vs-Stage3 |
5.69350000478863E-08 |
Normal-vs-Stage4 |
5.76509950889204E-10 |
Stage1-vs-Stage2 |
1.549620E-01 |
Stage1-vs-Stage3 |
1.379640E-02 |
Stage1-vs-Stage4 |
1.261090E-03 |
Stage2-vs-Stage3 |
6.610000E-01 |
Stage2-vs-Stage4 |
1.946400E-01 |
Stage3-vs-Stage4 |
3.565600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.63400001599257E-09 |
Normal-vs-AfricanAmerican |
1.56002999999183E-05 |
Normal-vs-Asian |
9.077000E-01 |
Caucasian-vs-AfricanAmerican |
3.937000E-01 |
Caucasian-vs-Asian |
2.924300E-02 |
AfricanAmerican-vs-Asian |
3.662400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.20019999389132E-09 |
Normal-vs-Female |
3.05960000002159E-06 |
Male-vs-Female |
2.409600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.658700E-03 |
Normal-vs-Age(41-60Yrs) |
1.06909999997296E-06 |
Normal-vs-Age(61-80Yrs) |
1.14070000112321E-08 |
Normal-vs-Age(81-100Yrs) |
7.71580000000771E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.125000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.214000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.047000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.650980E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.634550E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.278000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.525000E-01 |
Normal-vs-Grade 2 |
4.66899999995718E-06 |
Normal-vs-Grade 3 |
1.54150026077104E-10 |
Normal-vs-Grade 4 |
6.91489999704586E-08 |
Grade 1-vs-Grade 2 |
3.007200E-01 |
Grade 1-vs-Grade 3 |
4.405500E-02 |
Grade 1-vs-Grade 4 |
4.048300E-02 |
Grade 2-vs-Grade 3 |
2.615500E-02 |
Grade 2-vs-Grade 4 |
2.751900E-02 |
Grade 3-vs-Grade 4 |
4.471800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.90960000001628E-06 |
Normal-vs-ccB subtype |
4.24300000000377E-05 |
ccA subtype-vs-ccB subtype |
5.851800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.01509999797622E-08 |
Normal-vs-N1 |
7.386400E-01 |
N0-vs-N1 |
2.993000E-01 |
|
|